Test 3: Wk11: 5 Anti- Tuberculosis Drugs - Allman Flashcards
can pts with latent TB spread TB to others
no
MDR TB
resistant to at least INH and RIF
pts with resistance to Rifampin alone
better prognosis than MDR strains however at increased risk of tx failure/ addition resistance
XDR TB
extensive drug resistance
Resistant to INF and RIF plus FQN and at least one of the three injectable drugs
Life cycle of TB
- Active M tuberculosis
- Macrophage
- Walled off by macrophage
- Leukocytes
- Granuloma
- Active M tuberculosis
Prolonged treatment is required for successful eradication
Typically 6 months for routine Pulmonary TB Tx
TB Pericarditis and Meningitis
Initial adjunctive corticosteroid therapy with dexamethasone should be given for 6 weeks for ptns with TB Meningitis
Initial adjunctive corticosteroid therapy should not be routinely used; reserved for only selected ptns
ART CD4 <50/mm3
Start ART within first 2 weeks of TB treatment
CD4 >50/mm3
Start ART by 8-12 weeks of TB treatment
TB meningitis tx
TB meningitis = Do NOT start before 8 10 weeks of TB treatment
pts w/ HIV and TB have increased risk of
developing paradoxical worsening of sx and clinical manifestations of TB
Immune Reconstitution Inflammatory Syndrome IRIS
in HIV pts rxns develop as a consequence of reconstitution of immune responsiveness brought on by ART
Signs of IRIS may include (7)
High fevers
Worsening respiratory symptoms
Increase in size and inflammation of involved lymph nodes, new lymphadenopathy,
Expanding central nervous system (CNS) lesions,
Worsening of pulmonary parenchymal infiltrations
New or increasing pleural effusions
Development of intra abdominal or retroperitoneal abscesses
Starting ART within 2 weeks after starting tuberculosis therapy have higher
rates of — than those who start between 8 12 weeks
IRIS
does development of IRIS worsen treatment outcomes for either TB or HIV infection
no
IRIS may cause
severe or fatal neurological complications
Intensive Phase of TB tx
2 months (knocking down the volume)
Continuation Phase of TB tx
4 months (de escalate)
Dosing Guidelines
Daily dosing
Twice or Thrice weekly dosing
TB therapy requires
Requires Directly Observed Therapy (DOT)
4 first line agents for TB
isoniazid
Ethambutol
Pyrazinamide
Rifampin
Isoniazid function
inhibits cell wall synthesis
Ethambutol function
inhibits cell wall synthesis
Pyrazinamide function
direct target unclear
disrupts plasma membrane
disrupts energy metabolism
Rifampin function
inhibits RNA synthesis
3 Major Rifamycins
Rifampin
Rifabutin
Rifapentine
Rifampin
Mechanism of Action
inhibits DNA dependent RNA pol - suppression of initiation of chain formation in RNA Synthesis
Rifampin bactericidal function
Bactericidal: kills slow growing mycobacteria present within
macrophages and in caseating granulomas
Rifampin is active against
Active against some gram positive and gram negative bacteria.
(Reserved for TB, except in very rare
Rifampin Combination therapy with
INH
Rifampin Distribution
Widely distributed; excellent tissue distribution
CNS, tuberculosis abscesses, and intracellular sites
Rifampin Metabolism
Primarily metabolized by deacetylation
Autoinduction of metabolism occurs
Maximal induction at ~ 6 doses, whether given daily or twice weekly
Rifampin
Adverse Effects
Transient elevation in serum transaminases
Hepatotoxicity (rare)
GI upset (frequent)
Hypersensitivity (rare)
Discoloration of bodily fluids
what drug causes orange discoloration of sweat tears and urine
Rifampin
Rifampin Hepatotoxicity
Risk factors: alcoholics with preexisting liver disease.
Augmented when combined with INH
Rifampin
Hypersensitivity (rare)
Flushing, fever, pruritus
Systemic flu like syndrome
Thrombocytopenia
Rifampin
Drug Interactions
Proliferation of the smooth endoplasmic reticulum in
hepatocytes
Results in an increase in cytochrome p 450 (CP450) activity.
Rifampin increases metabolism of
P450
Warfarin
Theophylline
Narcotics
Oral Hypoglycemics
Steroids (oral contraceptives)
Rifampin
Place in Therapy
Treatment of active TB
2nd line agent for preventative therapy
Rifamycin derivative.
Rifabutin (Mycobutin)
when is rifabutin used
when pts are receiving meds with unacceptable interactions with Rifampin or had intolerance to rifampin
More active than rifampin against Mycobacterium avium
complex
Rifabutin (Mycobutin)
Rifabutin is used in the tx of
More active than rifampin against Mycobacterium avium
complex (MAC)
Rifabutin ADRs (7)
Rash GI Arthralgias Myalgias Discoloration of urine/sweat/ and tears neutropenia hepatoxicity
Used once weekly with INH in the continuation phase of
SPECIFIED treatment of TB
Rifapentine (Priftin)
Ptn must be HIV negative to use
Rifapentine (Priftin®)
pt must have — to take Rifapentine
Non cavitary , drug susceptible pulmonary tuberculosis who have
negative sputum smears at completion of the initial phase of treatment
advantage of Rifapentine
Once weekly
Rifapentine ADRs
similar to RIfampin
Isoniazid (INH)
Mechanism of Action
Inhibits synthesis of mycolic acid
Important constituent of mycobacterial cell walls
— Actively transported into bacterium
INH
INH kills actively growing organisms in
the extracellular environment
INH inhibits
growth of formant organisms within macrophages preventing granulomas
INH metabolism
Primarily acetylation
INH important metabolite
Monoacetyl hydrazine
Monoacetyl hydrazine excreted
in urine or further acetylated to diacyl form or hydroxylated to electrophile intermediated
— is responsible for hepatotoxic effects with INH
electrophile intermediated
Rates of acetylation of INH & mono acetyl hydrazine dependent on
Dependent on an individual’s phenotypic classification